SIA-IgG confers poor prognosis and represents a novel therapeutic target in breast cancer

References

• Dong Y, Liao H, Yu J, et al. Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer. J Nanobiotechnology. 2019;17(1):125.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao CK, Li XL, et al. Virtual touch tissue imaging and quantification: value in malignancy prediction for complex cystic and solid breast lesions. Sci Rep. 2017;7(1):7807.
   PubMed Web of Science ®Google Scholar
• Yao Y, Li X, Cheng L, et al. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway. Bioengineered. 2021;12(1):4032–4043.
   PubMed Web of Science ®Google Scholar
• Hennigs A, Riedel F, Gondos A, et al. Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer. 2016;16(1):1–9.
   Web of Science ®Google Scholar
• Abu-Thuraia A, Goyette MA, Boulais J, et al. AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network. Nat Commun. 2020;11(1):3586.
   PubMed Web of Science ®Google Scholar
• Xiu B, Chi Y, Liu L, et al. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Mol Cancer. 2019;18(1):187.
   PubMed Web of Science ®Google Scholar
• Liu R, Shi P, Nie Z, et al. Mifepristone suppresses basal triple-negative breast cancer stem cells by down-regulating KLF5 expression. Theranostics. 2016;6(4):533–544.
   PubMed Web of Science ®Google Scholar
• Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138(4):645–659.
   PubMed Web of Science ®Google Scholar
• Tong M, Deng Z, Yang M, et al. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells. Cancer Commun (Lond). 2018;38(1):56.
   PubMed Web of Science ®Google Scholar
• Jegatheeswaran S, Asnani A, Forman A, et al. Recognition of dimeric Lewis X by Anti-Dimeric Le(x) antibody SH2. Vaccines (Basel). 2020;8(3). DOI:10.3390/vaccines8030538.
   PubMed Web of Science ®Google Scholar
• Haudek KC, Patterson RJ, Wang JL. SR proteins and galectins: what’s in a name? Glycobiology. 2010;20(10):1199–1207.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhu J, Lubman DM, et al. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. Clin Chem Lab Med. 2019;57(4):407–416.
   PubMed Web of Science ®Google Scholar
• Cheng WK, Oon CE. How glycosylation aids tumor angiogenesis: an updated review. Biomed Pharmacother. 2018;103:1246–1252.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Lang JY, Hung MC, et al. Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin. J Biol Chem. 2011;286(33):29127–29138.
   PubMed Web of Science ®Google Scholar
• Kolbl AC, Andergassen U, Jeschke U. The role of glycosylation in breast cancer metastasis and cancer control. Front Oncol. 2015;5:219.
   PubMed Web of Science ®Google Scholar
• Kamaruzman NI, Aziz NA, Poh CL, et al. Oncogenic signaling in tumorigenesis and applications of siRNA nanotherapeutics in breast cancer. Cancers (Basel). 2019;11(5):632.
   PubMed Web of Science ®Google Scholar
• Babbage G, Ottensmeier CH, Blaydes J, et al. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 2006;66(8):3996–4000.
   PubMed Web of Science ®Google Scholar
• Huang J, Sun X, Mao Y, et al. Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons. Int J Biochem Cell Biol. 2008;40(8):1604–1615.
   PubMed Web of Science ®Google Scholar
• Chen Z, Gu J. Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J. 2007;21(11):2931–2938.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wu L, Zhang L, et al. Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells. Cell Mol Immunol. 2010;7(4):279–286.
   PubMed Web of Science ®Google Scholar
• Niu N, Zhang J, Sun Y, et al. Expression and distribution of immunoglobulin G and its receptors in an immune privileged site: the eye. Cell Mol Life Sci. 2011;68(14):2481–2492.
   PubMed Web of Science ®Google Scholar
• Niu N, Zhang J, Guo Y, et al. Expression and distribution of immunoglobulin G and its receptors in the human nervous system. Int J Biochem Cell Biol. 2011;43(4):556–563.
   PubMed Web of Science ®Google Scholar
• Qiu X, Sun X, He Z, et al. Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia. Leukemia. 2013;27(1):92–99.
   PubMed Web of Science ®Google Scholar
• Zheng J, Huang J, Mao Y, et al. Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells. J Biol Chem. 2009;284(20):13610–13619.
   PubMed Web of Science ®Google Scholar
• Zhang S, Mao Y, Huang J, et al. Immunoglobulin gene locus events in epithelial cells of lactating mouse mammary glands. Cell Mol Life Sci. 2010;67(6):985–994.
   PubMed Web of Science ®Google Scholar
• Huang J, Sun X, Gong X, et al. Rearrangement and expression of the immunoglobulin mu-chain gene in human myeloid cells. Cell Mol Immunol. 2014;11(1):94–104.
   PubMed Web of Science ®Google Scholar
• Hu F, Zhang L, Zheng J, et al. Spontaneous production of immunoglobulin M in human epithelial cancer cells. PLoS One. 2012;7(12):e51423.
   PubMed Web of Science ®Google Scholar
• Liang PY, Li HY, Zhou ZY, et al. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma. Tumour Biol. 2013;34(3):1783–1791.
   PubMedGoogle Scholar
• Deng H, Ma J, Jing Z, et al. Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion. Mol Med Rep. 2018;17(4):5272–5282.
   PubMed Web of Science ®Google Scholar
• Jiang D, Ge J, Liao Q, et al. IgG and IgA with potential microbial-binding activity are expressed by normal human skin epidermal cells. Int J Mol Sci. 2015;16(2):2574–2590.
   PubMed Web of Science ®Google Scholar
• Qiu X, Zhu X, Zhang L, et al. Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Research. 2003;63(19):6488.
   PubMed Web of Science ®Google Scholar
• Chen Z, Huang X, Ye J, et al. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer. 2010;116(8):1953–1963.
   PubMed Web of Science ®Google Scholar
• Li X, Ni R, Chen J, et al. The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms. Pancreas. 2011;40(5):753–761.
   PubMed Web of Science ®Google Scholar
• Yang B, Ma C, Chen Z, et al. Correlation of immunoglobulin G expression and histological subtype and stage in breast cancer. PLoS One. 2013;8(3):e58706.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hu S, Korteweg C, et al. Expression of immunoglobulin G in esophageal squamous cell carcinomas and its association with tumor grade and Ki67. Hum Pathol. 2012;43(3):423–434.
   PubMed Web of Science ®Google Scholar
• Lee G, Ge B. Cancer cell expressions of immunoglobulin heavy chains with unique carbohydrate-associated biomarker. Cancer Biomark. 2009;5(4):177–188.
   PubMed Web of Science ®Google Scholar
• Lee G, Laflamme E, Chien CH, et al. Molecular identity of a pan cancer marker, CA215. Cancer Biol Ther. 2008;7(12):2007–2014.
   PubMed Web of Science ®Google Scholar
• Lee G. Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications. Cancer Biomark. 2009;5(3):137–142.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang J, Liu Y, et al. Lung squamous cell carcinoma cells express non-canonically glycosylated IgG that activates integrin-FAK signaling. Cancer Lett. 2018;430:148–159.
   PubMed Web of Science ®Google Scholar
• Liao Q, Liu W, Liu Y, et al. Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis. Oncotarget. 2015;6(37):40081–40094.
   PubMedGoogle Scholar
• Liu Y, Liu D, Wang C, et al. Binding of the monoclonal antibody RP215 to immunoglobulin G in metastatic lung adenocarcinomas is correlated with poor prognosis. Histopathology. 2015;67(5):645–653.
   PubMed Web of Science ®Google Scholar
• Qin C, Sheng Z, Huang X, et al. Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway. Prostate. 2020;80(13):1134–1144.
   PubMed Web of Science ®Google Scholar
• Cui M, You L, Zheng B, et al. High expression of cancer-derived glycosylated immunoglobulin G predicts poor prognosis in pancreatic ductal adenocarcinoma. J Cancer. 2020;11(8):2213–2221.
   PubMed Web of Science ®Google Scholar
• Sheng Z, Liu Y, Qin C, et al. IgG is involved in the migration and invasion of clear cell renal cell carcinoma. J Clin Pathol. 2016;69(6):497–504.
   PubMed Web of Science ®Google Scholar
• Sheng Z, Liu Y, Qin C, et al. Involvement of cancer-derived IgG in the proliferation, migration and invasion of bladder cancer cells. Oncology Letters. 2016;12(6):5113–5121.
   PubMed Web of Science ®Google Scholar
• Lee G, Cheung AP, Ge B, et al. CA215 and GnRH receptor as targets for cancer therapy. Cancer Immunol Immunother. 2012;61(10):1805–1817.
   PubMed Web of Science ®Google Scholar
• Lee G, Chu RA, Ting HH. Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody. Cancer Biol Ther. 2009;8(2):161–166.
   PubMed Web of Science ®Google Scholar
• Zhang G, Xu Z, Yu M, et al. Bcl-2 interacting protein 3 (BNIP3) promotes tumor growth in breast cancer under hypoxic conditions through an autophagy-dependent pathway. Bioengineered. 2022;13(3):6280–6292.
   PubMed Web of Science ®Google Scholar
• Xueqin T, Jinhong M, Yuping H. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/beta-catenin signaling pathway. Bioengineered. 2021;12(2):11567–11575.
   PubMed Web of Science ®Google Scholar
• Zhuang W, Niu T, Li Z. MicroRNA miR-145-5p regulates cell proliferation and cell migration in colon cancer by inhibiting chemokine (C-X-C motif) ligand 1 and integrin alpha2. Bioengineered. 2021;12(2):9909–9917.
   PubMed Web of Science ®Google Scholar
• Liang S, Zhang X, Li J. Zinc finger Asp-His-His-Cys palmitoyl -acyltransferase 19 accelerates tumor progression through wnt/beta-catenin pathway and is upregulated by miR-940 in osteosarcoma. Bioengineered. 2022;13(3):7367–7379.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shang L, Jiang W, et al. Shikonin induces apoptosis and autophagy via downregulation of pyrroline-5-carboxylate reductase1 in hepatocellular carcinoma cells. Bioengineered. 2022;13(3):7904–7918.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Li C, Jin W, Zhang D, et al. Clinical significance of microRNA-1180-3p for colorectal cancer and effect of its alteration on cell function. Bioengineered. 2021;12(2):10491–10500.
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kumada T, Tada T, et al. Differences in the impact of prognostic factors for hepatocellular carcinoma over time. Cancer Science. 2017;108(12):2438–2444.
   PubMed Web of Science ®Google Scholar